Antenatal screening for Down's syndrome

Comment

T M Reynolds. Lancet. 1998.

. 1998 Oct 3;352(9134):1145.

doi: 10.1016/s0140-6736(05)79785-3.

No abstract available

Comment in

Antenatal screening for Down's syndrome.
Monni G, Ibba RM, Zoppi MA. Monni G, et al. Lancet. 1998 Nov 14;352(9140):1631-2. doi: 10.1016/s0140-6736(05)61084-7. Lancet. 1998. PMID: 9843137 No abstract available.

Antenatal screening for Down's syndrome: where are we and where next?
Haddow JE. Haddow JE. Lancet. 1998 Aug 1;352(9125):336-7. doi: 10.1016/S0140-6736(98)22031-9. Lancet. 1998. PMID: 9717914 No abstract available.
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. Snijders RJ, et al. Lancet. 1998 Aug 1;352(9125):343-6. doi: 10.1016/s0140-6736(97)11280-6. Lancet. 1998. PMID: 9717920